Cargando…
The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke
PURPOSE: To investigated the effectiveness of antiplatelet agents for the secondary prevention of stroke according to CYP2C19 genotype in patients with ischemic stroke (IS). METHODS: Between August 2009 and December 2011, 570 acute IS patients with acute large-artery atherosclerosis were randomly as...
Autores principales: | Yi, Xingyang, Lin, Jing, Zhou, Ju, Wang, Yanfeng, Huang, Ruyue, Wang, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915151/ https://www.ncbi.nlm.nih.gov/pubmed/29707143 http://dx.doi.org/10.18632/oncotarget.24877 |
Ejemplares similares
-
Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke
por: Yi, Xingyang, et al.
Publicado: (2016) -
Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping
por: Han, Sang Won, et al.
Publicado: (2017) -
Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: protocol for multicentre observational study
por: Song, Tae-Jin, et al.
Publicado: (2020) -
Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke
por: Rosário, Madalena, et al.
Publicado: (2023) -
Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis
por: Elfaki, Imadeldin, et al.
Publicado: (2018)